Exchange: OTC·Updated 09:34 AM EST

About VXLLF

About

Vaxil Bio Ltd. is a biotechnology company engaged in the development of signal peptide-based immunotherapies for the treatment of cancer and infectious diseases. Its pipeline consists of ImMucin, SPmAb2, SPmAb6, and MTbuVax. The company was founded on July 26, 2006 and is headquartered in Toronto, Canada.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

Advertisement|Remove ads.